Notch signalling in solid tumours: a little bit of everything but not all the time - PubMed (original) (raw)

Review

doi: 10.1038/nrc3035. Epub 2011 Apr 14.

Affiliations

• PMID: 21508972
• DOI: 10.1038/nrc3035

Review

Notch signalling in solid tumours: a little bit of everything but not all the time

Prathibha Ranganathan et al. Nat Rev Cancer. 2011 May.

Abstract

The discovery of Notch in Drosophila melanogaster nearly a century ago opened the door to an ever-widening understanding of cellular processes that are controlled or influenced by Notch signalling. As would be expected with such a pleiotropic pathway, the deregulation of Notch signalling leads to several pathological conditions, including cancer. A role for Notch is well established in haematological malignancies, and more recent studies have provided evidence for the importance of Notch activity in solid tumours. As it is thought to act as an oncogene in some cancers but as a tumour suppressor in others, the role of Notch in solid tumours seems to be highly context dependent.

PubMed Disclaimer

Similar articles

• Notch as a tumour suppressor.
  Nowell CS, Radtke F. Nowell CS, et al. Nat Rev Cancer. 2017 Mar;17(3):145-159. doi: 10.1038/nrc.2016.145. Epub 2017 Feb 3. Nat Rev Cancer. 2017. PMID: 28154375 Review.
• Dichotomy of Notch signalling in regulating tumour immune surveillance.
  Khosla R, Vyas AK, Trehanpati N. Khosla R, et al. Scand J Immunol. 2019 Mar;89(3):e12744. doi: 10.1111/sji.12744. Epub 2019 Jan 15. Scand J Immunol. 2019. PMID: 30548971 Review.
• Notch signalling in T-cell lymphoblastic leukaemia/lymphoma and other haematological malignancies.
  Aster JC, Blacklow SC, Pear WS. Aster JC, et al. J Pathol. 2011 Jan;223(2):262-73. doi: 10.1002/path.2789. Epub 2010 Oct 21. J Pathol. 2011. PMID: 20967796 Free PMC article. Review.
• Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think.
  Lobry C, Oh P, Aifantis I. Lobry C, et al. J Exp Med. 2011 Sep 26;208(10):1931-5. doi: 10.1084/jem.20111855. J Exp Med. 2011. PMID: 21948802 Free PMC article. Review.
• Hypoxia, notch signalling, and prostate cancer.
  Marignol L, Rivera-Figueroa K, Lynch T, Hollywood D. Marignol L, et al. Nat Rev Urol. 2013 Jul;10(7):405-13. doi: 10.1038/nrurol.2013.110. Epub 2013 May 28. Nat Rev Urol. 2013. PMID: 23712204 Free PMC article. Review.

Cited by

• Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy.
  Li Q, Geng S, Luo H, Wang W, Mo YQ, Luo Q, Wang L, Song GB, Sheng JP, Xu B. Li Q, et al. Signal Transduct Target Ther. 2024 Oct 7;9(1):266. doi: 10.1038/s41392-024-01953-7. Signal Transduct Target Ther. 2024. PMID: 39370455 Free PMC article. Review.
• Targeted therapy of cancer stem cells: inhibition of mTOR in pre-clinical and clinical research.
  Son B, Lee W, Kim H, Shin H, Park HH. Son B, et al. Cell Death Dis. 2024 Sep 30;15(9):696. doi: 10.1038/s41419-024-07077-8. Cell Death Dis. 2024. PMID: 39349424 Free PMC article. Review.
• Unveiling the Dynamic Interplay between Cancer Stem Cells and the Tumor Microenvironment in Melanoma: Implications for Novel Therapeutic Strategies.
  Limonta P, Chiaramonte R, Casati L. Limonta P, et al. Cancers (Basel). 2024 Aug 16;16(16):2861. doi: 10.3390/cancers16162861. Cancers (Basel). 2024. PMID: 39199632 Free PMC article. Review.
• Cancer-wide in silico analyses using differentially expressed genes demonstrate the functions and clinical relevance of JAG, DLL, and NOTCH.
  Kim JY, Hong N, Ham SW, Park S, Seo S, Kim H. Kim JY, et al. PLoS One. 2024 Jul 29;19(7):e0307943. doi: 10.1371/journal.pone.0307943. eCollection 2024. PLoS One. 2024. PMID: 39074091 Free PMC article.
• Inhibition of NOTCH4 sensitizes FLT3/ITD acute myeloid leukemia cells to FLT3 tyrosine kinase inhibition.
  Zhu R, Shirley CM, Chu SH, Li L, Nguyen BH, Seo J, Wu M, Seale T, Duffield AS, Staudt LM, Levis M, Hu Y, Small D. Zhu R, et al. Leukemia. 2024 Jul;38(7):1581-1591. doi: 10.1038/s41375-024-02292-w. Epub 2024 May 29. Leukemia. 2024. PMID: 38811818

References

1. 1. Mol Cell Biol. 2001 Nov;21(21):7403-15 - PubMed
2. 1. Nature. 2006 Dec 7;444(7120):756-60 - PubMed
3. 1. J Neurosci Res. 2009 Dec;87(16):3521-34 - PubMed
4. 1. J Exp Med. 2007 Nov 26;204(12):2935-48 - PubMed
5. 1. Nat Genet. 2000 Mar;24(3):245-50 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)

• Research Materials

  • NCI CPTC Antibody Characterization Program